The usage of Utrogestan and hMG protocol in patients with polycystic ovarian syndrome undergoing controlled ovarian hyperstimulation during IVF/ICSI treatments

被引：0
|
作者：
Zhu, X. [1 ]
Fu, Y. [1 ]
机构：
[1] Shanghai Ninth Peoples Hosp, Dept Assisted Reprod, Shanghai, Peoples R China
来源：
HUMAN REPRODUCTION | 2016年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
P-677
引用
收藏
页码：420 / 421
页数：2
相关论文
共 50 条
  • [1] The Utrogestan and hMG protocol in patients with polycystic ovarian syndrome undergoing controlled ovarian hyperstimulation during IVF/ICSI treatments
    Zhu, Xiuxian
    Ye, Hongjuan
    Fu, Yonglun
    [J]. MEDICINE, 2016, 95 (28)
  • [2] The dydrogesterone and FSH protocol in patients with polycystic ovarian syndrome undergoing controlled ovarian hyperstimulation in IVF/ICSI cycle
    Gurbuz, A. S.
    Gode, F.
    [J]. HUMAN REPRODUCTION, 2019, 34 : 107 - 107
  • [3] The usage of Daphaston and hMG protocol in normalovulatory women undergoing controlled ovarian hyperstimulation during IVF/ICSI treatments in combination with embryo cryopreservation
    Zhu, X.
    Ye, H.
    Fu, Y.
    [J]. HUMAN REPRODUCTION, 2017, 32 : 447 - 447
  • [4] Factors Associated with Ovarian Hyperstimulation Syndrome (OHSS) Severity in Women With Polycystic Ovary Syndrome Undergoing IVF/ICSI
    Sun, Bo
    Ma, Yujia
    Li, Lu
    Hu, Linli
    Wang, Fang
    Zhang, Yile
    Dai, Shanjun
    Sun, Yingpu
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2021, 11
  • [5] The role of Loratadin in prevention of ovarian hyperstimulation syndrome in patients undergoing IVF/ICSI cycles
    Madani, T.
    Ashrafi, M.
    Khafri, S.
    Irani, S.
    [J]. HUMAN REPRODUCTION, 2007, 22 : I146 - I146
  • [6] Does the phenotype of polycystic ovary syndrome influence the ovarian response to controlled ovarian hyperstimulation for IVF?
    Robin, G.
    Grysole, C.
    Uk, A.
    Barbotin, A. L.
    Decanter, C.
    Dewailly, D.
    [J]. HUMAN REPRODUCTION, 2018, 33 : 466 - 467
  • [7] Encountering premature ovulation during controlled ovarian hyperstimulation in IVF/ICSI cycles
    Wu, Frank Shao-Ying
    Lee, Robert Kuo-Kuang
    Hwu, Yuh-Ming
    [J]. TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2012, 51 (02): : 256 - 259
  • [8] Changes in Coagulation and Fibrinolytic Indices in Women with Polycystic Ovarian Syndrome Undergoing Controlled Ovarian Hyperstimulation
    Huang, Ying
    Zhao, Yong
    Yan, Ling
    Chuai, Yun-Hai
    Liu, Ling-Ling
    Chen, Yi
    Li, Min
    Wang, Ai-Ming
    [J]. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2014, 2014
  • [9] Methylprednisolone for prevention of ovarian hyperstimulation syndrome in patients with polycystic ovarian syndrome undergoing in-vitro fertilisation: a randomised controlled trial
    Yeganeh, Ladan Mohammadi
    Moini, Ashraf
    Shiva, Marzieh
    Mirghavam, Naimeh
    Lankarani, Narges Bagheri
    [J]. JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2018, 38 (02) : 241 - 246
  • [10] Serum GDF-8 levels change dynamically during controlled ovarian hyperstimulation in patients undergoing IVF/ICSI-ET
    Fang, Lanlan
    Yu, Yiping
    Zhang, Ruizhe
    He, Jingyan
    Sun, Ying-Pu
    [J]. SCIENTIFIC REPORTS, 2016, 6
12345